for a number of reasons, such as keeping FT Sites reliable and secure,
personalising content and ads, providing social media features and to
analyse how our Sites are used.
Your guide to a disrupted world
Add this topic to your myFT Digest for news straight to your inbox
Private equity group also buys stake in Merck Mercuriadis’s company as valuations boom
Private funds gain superior visibility into business prospects
Building materials are safe as houses but only at a price; Hipgnosis’ sketchy disclosure hits all the wrong notes
The acquisitive song royalty fund shows no sign of shifting tempo.
London-listed group also scoops up Metallica producer’s catalogue as frenetic pace of acquisitions continues
The sellside have heard a bum note, or four.
Merck Mercuriadis’s group continues spending spree on hit catalogues
Beats co-founder known for work with John Lennon and Bruce Springsteen is latest to cash in on music rights boom
Songwriters deprived of touring revenue are cashing in their back catalogues but will it pay off?
Merck Mercuriadis’s music publishing group seeks to sustain spending on hit catalogues
Hipgnosis eyes £1bn deal; Warner streaming shock, a defence of Philip Green
British music fund picks up 33,000 titles in biggest acquisition to date
Music publishing company follows Hipgnosis in raising equity
This is a risky binary stock, destined for spectacular hits or misses
UK company expands song rights catalogue and adds publishing to its portfolio
Merck Mercuriadis adds to portfolio with hits including ‘Heart of Glass’ and ‘Call Me’